Skip to content

Detection of early biological responses induced by a food component (preliminary study)

Detection of early biological responses induced by ingestion of a food ingredients that activate gastrointestinal vagal afferent pathways (preliminary study) - Detection of early biological responses induced by ingestion of a food ingredients that activate gastrointestinal vagal afferent pathways (preliminary study)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000057973
Enrollment
12
Registered
2026-05-31
Start date
2025-05-22
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male adults

Interventions

Sponsors

Yakult Honsha Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1.Healthy males aged 20 to below 60 years at the time of consent acquisition. 2.Office workers 3.Subjects whose average sleep duration is over 6 hours 4.Subjects whose day-to-day variability in bedtime and wake-up time on weekdays is within 2 hours. 5.Subjects who can go to bed before midnight on the day before the test. 6.Subjects who commute by walking or biking (with the duration of approx. 5 to 30 minutes) 7.Subjects who give written informed consent, after receiving a detailed explanation of the study protocol and understanding the provided information.

Exclusion criteria

Exclusion criteria: 1.Subjects with a history or current diagnosis of mental disorders, chronic fatigue syndrome, sleep disorders, brain injury, brain dysfunction, learning disabilities, or dementia. 2.Subjects with a history or current diagnosis of diabetes, liver disease, kidney disease, heart disease, respiratory disease, diseases affecting adrenal cortex hormone secretion, or other metabolic diseases. 3.Subjects who are currently undergoing medication treatment. 4.Subjects who have smoking habits. 5.Subjects who daily take excessive alcohol. 6.Subjects who are unable to refrain from exercise on the test day (excluding physical activity related to commuting) until the end of blood sampling. 7.Subjects whose sleep environment may change significantly due to long-term business trips or travel during the study period. 8.Subjects who have a participation in other clinical trials within the last 4 weeks or are intended to participate. 9.Subjects who have allergies to medications and/or food. 10.Subjects who have been considered ineligible for participation in the trial by the investigators.

Design outcomes

Primary

MeasureTime frame
Plasma concentrations of proteins downstream of signaling pathways stimulated by the test food component

Secondary

MeasureTime frame
Plasma concentrations of gastrointestinal hormones Correlation between plasma concentrations of proteins and gastrointestinal hormones that showed significant expression changes in the primary endpoints Changes in the plasma proteome associated with the ingestion of the test food component

Countries

Japan

Contacts

Public ContactKazunori Matsuda

Yakult Honsha Co., Ltd. Food Research Department

kazunori-matsuda@yakult.co.jp042-577-8946

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026